Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Hercules Pharmaceuticals logo — Driving Innovation in Non-Toxic Oral Therapies for Triple Ne...

Hercules Pharmaceuticals

Driving Innovation in Non-Toxic Oral Therapies for Triple Negative Breast Cancer and Solid Tumors

Founded 2013 Seed Total: $300.00K Biopharma, Biotechnology

General Information

Company Name Hercules Pharmaceuticals
Founded Year 2013
Industries Biopharma, Biotechnology
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Hercules Pharmaceuticals. To contact Hercules Pharmaceuticals, visit hercules-pharma.nl.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Hercules Pharmaceuticals compare?

A PDF of Hercules Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Hercules Pharmaceuticals soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Hercules Pharmaceuticals

Hercules Pharmaceuticals is a biopharmaceutical company founded in 2013 with a mission to develop innovative, oral, non-toxic drug therapies for patients with Triple Negative Breast Cancer and other solid tumors. The company's focus on inhibiting the Aryl hydrocarbon Receptor in solid tumors has shown promising results including enhancing the immune system's response to cancer, decreasing the likelihood of relapses, reducing metastatic tendencies, lowering the aggression of existing cancer, and increasing cancer cells' sensitivity to standard chemotherapy. Hercules has made significant strides in discovering novel anti-cancer drugs that block the Aryl Hydrocarbon receptor and is in the process of preparing for clinical trials. The company received a €300.00K Seed Round investment on 24 August 2017 from UNIIQ, signifying confidence in its groundbreaking approach to cancer treatment in the Biopharma and Biotechnology industries.

Business keywords: biopharmaceutical, oral therapy, non-toxic, Triple Negative Breast Cancer, solid tumors, Aryl hydrocarbon Receptor, anti-cancer drugs, clinical trials, cancer treatment, immunotherapy, metastasis, chemotherapy, cancer research, drug development, oncology

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round €300.00K 1
UNIIQ
24 Aug 2017

Hercules Pharmaceuticals Alternatives & Competitors

View All Alternatives
Hercules Pharmaceuticals vs
Epsilogen Ltd
Epsilogen Ltd United Kingdom

Harnessing the power of IgE

Series B
33 employees
Biopharma, Biotechnology
Compare Hercules Pharmaceuticals vs Epsilogen Ltd
Hercules Pharmaceuticals vs
ORIC Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc. United States

Overcoming Resistance In Cancer

Post-IPO Equity
119 employees
Biopharma, Biotechnology
Hercules Pharmaceuticals vs
Prescient Therapeutics
Prescient Therapeutics Australia

A clinical stage oncology company developing personalised medicine approaches to cancer; cellular &...

Post-IPO Equity
14 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Hercules Pharmaceuticals

Driving Innovation in Non-Toxic Oral Therapies for Triple Negative Breast Cancer and Solid Tumors
Hercules Pharmaceuticals was founded in 2013.
Hercules Pharmaceuticals operates in Biopharma and Biotechnology. Its work centres on biopharmaceutical, oral therapy, non-toxic and Triple Negative Breast Cancer.
Hercules Pharmaceuticals has completed 1 funding round, raising a total of $300.00K. The latest funding stage is Seed.
Top alternatives and competitors to Hercules Pharmaceuticals include Epsilogen Ltd, ORIC Pharmaceuticals Inc., Prescient Therapeutics, Seneca Therapeutics, Inc., Genelux. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Hercules Pharmaceuticals and Epsilogen Ltd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Hercules Pharmaceuticals, https://bouncewatch.com/company/hercules-pharmaceuticals, updated 13 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout